Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T15:10:50.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a pembrolizumab study in recurrent or metastatic medullary thyroid cancer is displayed, with study details and results information. Previously, the page showed a 403 Forbidden error.
    Difference
    63%
    Check dated 2026-11-07T14:51:47.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:38:04.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces an update about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T18:38:18.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T20:34:06.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1. The page still displays a 403 error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-10T20:47:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.